https://www.aao.org/interview/light-activated-nanoparticle-therapy-uveal-melanom In this interview from AAO 2019, Dr. Carol Shields discusses a new light-activated nanoparticle therapy (AU-011) for ocular melanoma. The particle, which is attached to a chromophore, binds to melanoma cells and is activated by a 689-nanometer light. Early-stage trials look promising, she explains, with preliminary results demonstrating minimal vision loss, suggesting this […]
https://www.aao.org/1-minute-video/multimodal-imaging-signs-of-malignant-transformati In this 1-Minute Video, Dr. Carol Shields offers tips for managing patients who present with a pigmented lesion at the back of the eye. Risk factors that predict the transformation of choroidal nevus in melanoma can be remembered with the following mnemonic: To Find Small Ocular Melanoma Doing IMaging. T: thickness over two millimeters; […]
A Story of Frustrations, Close Calls, Fun, and Lucky Breaks. The Autobiography of Jerry A. Shields, M.D. Available at Blurb
In this 1-Minute video, Dr. Carol Shields offers advice for treating iris melanoma. Ocular oncologists generally devise treatment strategies based on tumor size, location and shedding of pigment. Small tumors are typically resected, while large tumors might be treated with radiotherapy. But enucleation may be necessary for tumors that have shed pigment. Tube shunts and […]
Join the Melanoma Research Foundation’s FREE, educational webinar! This LIVE program will feature a 4-speaker panel to review current trends in ocular melanoma diagnosis, management and treatment, including ongoing clinical trials. View Here!
ReMission Foundation, with the support of Love From Liam and Eye Tumor Research Foundation, is pleased to support: Carol Shields, M.D. Director of the Oncology Service at Wills Eye Hospital & Professor of Ophthalmology at Thomas Jefferson University in Philadelphia, and her retinoblastoma cancer research. Read more about ReMission Foundation.